Leandro-García LJ, Leskelä S, Inglada-Pérez L, Landa I, de Cubas AA, Maliszewska A, Comino-Méndez I, Letón R, Gómez-Graña Á, Torres R, Ramírez JC, Álvarez S, Rivera J, Martínez C, Lozano ML, Cascón A, Robledo M, Rodríguez-Antona C. Hematologic ?-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity. Cancer Res. 2012 Sep 15;72(18):4744-52. doi: 10.1158/0008-5472.CAN-11-2861. Epub 2012 Jul 17. PubMed PMID: 22805305.
AÑO: 2012; IF: 8.65
|
Martínez-Martínez I, Navarro-Fernández J, Aguila S, Miñano A, Bohdan N, De La Morena-Barrio ME, Ordóñez A, Martínez C, Vicente V, Corral J. The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency. Mol Med. 2012 Jul 18;18:762-70. doi: 10.2119/molmed.2012.00017. PubMed PMID: 22481271; PubMed Central PMCID: PMC3409284.
AÑO: 2012; IF: 6.354
|
Guerrero JA, Teruel R, Martínez C, Arcas I, Martínez-Martínez I, de la Morena-Barrio ME, Vicente V, Corral J. Protective role of antithrombin in mouse models of liver injury. J Hepatol. 2012 Nov;57(5):980-6. doi: 10.1016/j.jhep.2012.06.023. Epub 2012 Jun 26. PubMed PMID: 22749941.
AÑO: 2012; IF: 25.083
|
Martínez-Martínez I, Navarro-Fernández J, Østergaard A, Gutiérrez-Gallego R, Padilla J, Bohdan N, Miñano A, Pascual C, Martínez C, de la Morena-Barrio ME, Aguila S, Pedersen S, Kristensen SR, Vicente V, Corral J. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. Blood. 2012 Jul 26;120(4):900-4. doi: 10.1182/blood-2012-01-406207. Epub 2012 Apr 12. PubMed PMID: 22498748.
AÑO: 2012; IF: 22.113
|
Sánchez-Guiu I, Antón AI, García-Barberá N, Navarro-Fernández J, Martínez C, Fuster JL, Couselo JM, Ortuño FJ, Vicente V, Rivera J, Lozano ML. Chediak-Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype. Eur J Haematol. 2014 Jan;92(1):49-58. doi: 10.1111/ejh.12203. PubMed PMID: 24112114.
AÑO: 2014; IF: 2.066
|